Literature DB >> 18281611

HIF-2alpha-haploinsufficient mice have blunted retinal neovascularization due to impaired expression of a proangiogenic gene battery.

Elhadji M Dioum1, Stephen L Clarke, Kan Ding, Joyce J Repa, Joseph A Garcia.   

Abstract

PURPOSE: To characterize the effect of HIF-2alpha haploinsufficiency on retinal neovascularization and angiogenic signaling in neonatal mice.
METHODS: Retinal samples were obtained from HIF-2alpha-haploinsufficient (Epas1+/-) and wild-type (Epas1+/+) neonatal mice subjected to an oxygen-induced retinopathy (OIR) protocol. Histologic and molecular studies were performed immediately, 12 hours, or 5 days after initiation of the hypoxia phase of the OIR protocol. Molecular profiling was performed in mouse brain endothelial cells maintained in normoxia or hypoxia. Transfection studies assessed the response of isolated promoter regions from proangiogenic genes to HIF-1alpha or -2alpha overexpression.
RESULTS: Epas1+/- mice exhibited no significant differences in retinal vasculature during normal development but had reduced retinal neovascularization in an OIR protocol. Multiple proangiogenic factors were induced during the hypoxia phase in Epas1+/+ OIR retinal samples, whereas Epas1+/- OIR retinal samples had absent or blunted induction of these same factors. Several, but not all, proangiogenic factors were induced in mouse brain endothelial cells after hypoxia. In transfection assays, most proangiogenic promoter regions were preferentially activated by HIF-2alpha relative to HIF-1alpha.
CONCLUSIONS: HIF-2alpha deficiency results in reduced neovascularization and blunted inducibility of multiple proangiogenic factors in the retinas of mice with OIR. The authors propose that HIF-2alpha is a master regulator of proangiogenic factors in retinal vascular endothelial cells, the predominant cell type of the retina in which HIF-2alpha is expressed. Future studies will address whether the molecular and functional roles for HIF-2alpha identified from these studies can be generalized to other pathophysiological states involving neovascularization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281611     DOI: 10.1167/iovs.07-1469

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  26 in total

Review 1.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

2.  Rapid and dynamic alterations of gene expression profiles of adult porcine bone marrow-derived stem cell in response to hypoxia.

Authors:  Suna Wang; Yifu Zhou; Caleb N Seavey; Avneesh K Singh; Xiuli Xu; Timothy Hunt; Robert F Hoyt; Keith A Horvath
Journal:  Stem Cell Res       Date:  2010-01-04       Impact factor: 2.020

3.  Methylene blue-induced neuronal protective mechanism against hypoxia-reoxygenation stress.

Authors:  M-G Ryou; G R Choudhury; W Li; A Winters; F Yuan; R Liu; S-H Yang
Journal:  Neuroscience       Date:  2015-06-03       Impact factor: 3.590

Review 4.  Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.

Authors:  Nanduri R Prabhakar; Gregg L Semenza
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

5.  Hypoxia increases sirtuin 1 expression in a hypoxia-inducible factor-dependent manner.

Authors:  Rui Chen; Elhadji M Dioum; Richard T Hogg; Robert D Gerard; Joseph A Garcia
Journal:  J Biol Chem       Date:  2011-02-23       Impact factor: 5.157

6.  Gene expression microarray analysis of early oxygen-induced retinopathy in the rat.

Authors:  Melinda Tea; Rhys Fogarty; Helen M Brereton; Michael Z Michael; Mark B Van der Hoek; Anna Tsykin; Douglas J Coster; Keryn A Williams
Journal:  J Ocul Biol Dis Infor       Date:  2009-12-12

7.  HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia.

Authors:  Freya M Mowat; Ulrich F O Luhmann; Alexander J Smith; Clemens Lange; Yanai Duran; Sarah Harten; Deepa Shukla; Patrick H Maxwell; Robin R Ali; James W B Bainbridge
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

8.  Adenoviral targeting of gene expression to tumors.

Authors:  R T Hogg; J A Garcia; R D Gerard
Journal:  Cancer Gene Ther       Date:  2010-02-05       Impact factor: 5.987

Review 9.  Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy.

Authors:  Elsa Kermorvant-Duchemin; Przemyslaw Sapieha; Mirna Sirinyan; Martin Beauchamp; Daniella Checchin; Pierre Hardy; Florian Sennlaub; Pierre Lachapelle; Sylvain Chemtob
Journal:  Doc Ophthalmol       Date:  2009-10-31       Impact factor: 2.379

10.  Synergistic effect of HIF-1alpha gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia.

Authors:  Sergio Rey; KangAe Lee; C Joanne Wang; Kshitiz Gupta; Shaoping Chen; Alexandra McMillan; Nupura Bhise; Andre Levchenko; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.